Multi-target enzyme inhibitors have gained a growing interest due to their fewer side effects compared to a single targeted or combination therapy. Medicinal plants can serve as a vast platform for bioactive molecules that could act as safe and effective multi-target enzyme inhibitors. Diabetes mellitus is a complicated metabolic disorder with several enzymes involved such as α-amylase, tyrosinase and hyaluronidase. Out of 54 tested extracts, P. emblica and T. diffusa leaves extract exerted the highest inhibitory effect against α-amylase with 98.37 and 60.16% inhibition, respectively. G. glabra stolon, propolis resin and C. splendens leaves extracts exhibited the highest tyrosinase inhibitory activity with 98.13 ± 0.80, 73.13 ± 0.51 and 65.52 ± 0.68% inhibition, respectively. On the other hand, hyaluronidase enzyme, P. granatum, P. emblica, and P. guajava, showed the highest activity at 116.34 ± 1.06% 115.77 ± 0.45%, and 103.44 ± 0.78% respectively. Subsequently, this study revealed that only 6 extracts; Calligonum comosum, Camellia sinensis, Clerodendrum splendens, Phyllanthus emblica, Rumex acetosa, and Turnera diffusa, retained a multi-target inhibitory effect on the three tested enzymes. Interestingly, all 6 plants except Calligonum comosum are commonly used in folkloric medicine for diabetes modulation and our results rationalize their traditional use. Furthermore, the antioxidant capacity and the total phenolic content were determined for all extracts, where they showed potential anti-oxidant capacity related to their high total phenolic content. The obtained results prompted us to a preliminary conclusion towards the potential use of medicinal plants as multi-target enzyme inhibitors for the modulation of metabolic diseases such as Diabetes mellitus.